- All sections
- C - Chemistrymetallurgy
- C07C - Acyclic or carbocyclic compounds
- C07C 313/06 - Sulfinamides
Patent holdings for IPC class C07C 313/06
Total number of patents in this class: 57
10-year publication summary
|
2
|
4
|
6
|
4
|
4
|
5
|
6
|
5
|
8
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Peloton Therapeutics, Inc. | 38 |
4 |
| Novartis AG | 10707 |
3 |
| Vitae Pharmaceuticals, Inc. | 95 |
3 |
| Oxford Drug Design Limited | 10 |
3 |
| Nikang Therapeutics, Inc. | 97 |
3 |
| Orsobio, Inc. | 13 |
3 |
| Boehringer Ingelheim International GmbH | 4644 |
2 |
| Alkermes Pharma Ireland Limited | 268 |
2 |
| Cytokinetics, Inc. | 284 |
2 |
| Piramal Pharma Limited | 54 |
2 |
| Genentech, Inc. | 4012 |
1 |
| Bayer Intellectual Property GmbH | 2486 |
1 |
| FUJIFILM Corporation | 29713 |
1 |
| Ricoh Company, Ltd. | 13391 |
1 |
| ABX Advanced Biochemical Compounds GmbH | 12 |
1 |
| Amira Pharmaceuticals, Inc. | 69 |
1 |
| Arbutus Biopharma Corporation | 177 |
1 |
| Kinex Pharmaceuticals, LLC | 11 |
1 |
| Nanjing University | 740 |
1 |
| Nanyang Technological University | 2043 |
1 |
| Other owners | 20 |